These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 22672816)
1. Key challenges to the development of extracorporeal bioartificial liver support systems. Zhao LF; Pan XP; Li LJ Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):243-9. PubMed ID: 22672816 [TBL] [Abstract][Full Text] [Related]
2. Progress in bioreactors of bioartificial livers. Yu CB; Pan XP; Li LJ Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025 [TBL] [Abstract][Full Text] [Related]
3. Bioartificial livers: a review of their design and manufacture. Tuerxun K; He J; Ibrahim I; Yusupu Z; Yasheng A; Xu Q; Tang R; Aikebaier A; Wu Y; Tuerdi M; Nijiati M; Zou X; Xu T Biofabrication; 2022 Jun; 14(3):. PubMed ID: 35545058 [TBL] [Abstract][Full Text] [Related]
5. In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL. Poyck PP; Pless G; Hoekstra R; Roth S; Van Wijk AC; Schwartländer R; Van Gulik TM; Sauer IM; Chamuleau RA Int J Artif Organs; 2007 Mar; 30(3):183-91. PubMed ID: 17417756 [TBL] [Abstract][Full Text] [Related]
6. Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications. van Wenum M; Chamuleau RA; van Gulik TM; Siliakus A; Seppen J; Hoekstra R Expert Opin Biol Ther; 2014 Dec; 14(12):1745-60. PubMed ID: 25366164 [TBL] [Abstract][Full Text] [Related]
7. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines. van Wenum M; Adam AA; Hakvoort TB; Hendriks EJ; Shevchenko V; van Gulik TM; Chamuleau RA; Hoekstra R Int J Biol Sci; 2016; 12(8):964-78. PubMed ID: 27489500 [TBL] [Abstract][Full Text] [Related]
8. Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells. Sakiyama R; Blau BJ; Miki T World J Gastroenterol; 2017 Mar; 23(11):1974-1979. PubMed ID: 28373763 [TBL] [Abstract][Full Text] [Related]
9. Bioartificial liver assist devices in support of patients with liver failure. Patzer II JF; Lopez RC; Zhu Y; Wang ZF; Mazariegos GV; Fung JJ Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):18-25. PubMed ID: 14607616 [TBL] [Abstract][Full Text] [Related]
10. Bioartificial liver support for fulminant hepatic failure. Anand AC Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S69-74. PubMed ID: 15025261 [TBL] [Abstract][Full Text] [Related]
11. Artificial and bioartificial liver devices: present and future. Carpentier B; Gautier A; Legallais C Gut; 2009 Dec; 58(12):1690-702. PubMed ID: 19923348 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure. Shito M; Tilles AW; Tompkins RG; Yarmush ML; Toner M J Surg Res; 2003 May; 111(1):53-62. PubMed ID: 12842448 [TBL] [Abstract][Full Text] [Related]
13. Transport advances in disposable bioreactors for liver tissue engineering. Catapano G; Patzer JF; Gerlach JC Adv Biochem Eng Biotechnol; 2009; 115():117-43. PubMed ID: 19499208 [TBL] [Abstract][Full Text] [Related]
14. Life support of artificial liver: development of a bioartificial liver to treat liver failure. Kobayashi N J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648 [TBL] [Abstract][Full Text] [Related]
15. Critical issues in bioartificial liver development. Tilles AW; Berthiaume F; Yarmush ML; Toner M Technol Health Care; 2002; 10(3-4):177-86. PubMed ID: 12118141 [TBL] [Abstract][Full Text] [Related]
17. Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application. Nibourg GA; Huisman MT; van der Hoeven TV; van Gulik TM; Chamuleau RA; Hoekstra R Liver Transpl; 2010 Sep; 16(9):1075-85. PubMed ID: 20818746 [TBL] [Abstract][Full Text] [Related]